Research Article

Complications and Functional Results of Surgery for Locally Advanced Prostate Cancer

Table 1

Patient characteristics.

Number of patients139

Age (years), mean (±SD)61,8 (±7,0)

cT3a89,9% ( )
cT3b10,1% ( )
Biopsy Gleason score, median (range)7 (2–10)
PSA (ng/mL), mean (range)13,73 (3,1–97,0)

Previous surgery14,4% ( )
Neo-Adjuvant Androgen Deprivation Therapy8,6% ( )
Non-nerve-sparing procedure92,8% ( )

Unilateral nerve sparing procedure7,2% ( )
Lymphadenectomy not performed7,2% ( )
Hospital stay (days), median (range)12 (5–27)

pT231,1% ( )
pT3a51,1% ( )
pT3b16,3% ( )
pT41,5% ( )

PSA persistence10,1% ( )
Pathological Gleason score, median (range)7 (4–9)
Pathological node positive10,1% ( )
Surgical margin positive13,7% ( )

Adj radiation therapy within 1 year7,2% ( )
Adj endocrine therapy within 1 year13,7% ( )